Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
In the latest session, CME Group Inc (NASDAQ: CME) closed at $262.05 down -0.99% from its previous closing price of $264.67. In other words, the price has decreased by -$0.99 from its previous closing price. On the day, 2.19 million shares were traded. CME stock price reached its highest trading level at $264.2 during the session, while it also had its lowest trading level at $258.19.
Ratios:
For a deeper understanding of CME Group Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 44.85 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 22.99. For the most recent quarter (mrq), Quick Ratio is recorded 1.02 and its Current Ratio is at 1.02. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.13.
On July 24, 2025, UBS Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $305.
Morgan Stanley Upgraded its Equal-Weight to Overweight on April 08, 2025, while the target price for the stock was maintained at $301.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 25 ’25 when SHEPARD WILLIAM R bought 262 shares for $265.19 per share. The transaction valued at 69,603 led to the insider holds 258,459 shares of the business.
SHEPARD WILLIAM R bought 12 shares of CME for $3,069 on Sep 25 ’25. The Director now owns 2,466 shares after completing the transaction at $265.22 per share. On Sep 18 ’25, another insider, Marcus Jonathan L, who serves as the Sr MD General Counsel of the company, sold 392 shares for $262.00 each. As a result, the insider received 102,704 and left with 7,851 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CME now has a Market Capitalization of 94437621760 and an Enterprise Value of 96112123904. As of this moment, CME’s Price-to-Earnings (P/E) ratio for their current fiscal year is 25.36, and their Forward P/E ratio for the next fiscal year is 22.68. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.22. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.66 while its Price-to-Book (P/B) ratio in mrq is 3.40. Its current Enterprise Value per Revenue stands at 14.941 whereas that against EBITDA is 21.137.
Stock Price History:
The Beta on a monthly basis for CME is 0.39, which has changed by 0.18210936 over the last 52 weeks, in comparison to a change of 0.1719923 over the same period for the S&P500. Over the past 52 weeks, CME has reached a high of $290.79, while it has fallen to a 52-week low of $208.75. The 50-Day Moving Average of the stock is -2.91%, while the 200-Day Moving Average is calculated to be -0.08%.
Shares Statistics:
For the past three months, CME has traded an average of 1.99M shares per day and 1855780 over the past ten days. A total of 359.65M shares are outstanding, with a floating share count of 358.81M. Insiders hold about 0.43% of the company’s shares, while institutions hold 90.79% stake in the company. Shares short for CME as of 1757894400 were 4629679 with a Short Ratio of 2.32, compared to 1755216000 on 5080621. Therefore, it implies a Short% of Shares Outstanding of 4629679 and a Short% of Float of 1.2899999500000001.
Dividends & Splits
According to the company, the forward annual dividend rate for CME is 4.87, from 4.8 in the trailing year. Against a Trailing Annual Dividend Yield of 0.018135792. The stock’s 5-year Average Dividend Yield is 3.46. The current Payout Ratio is 107.52% for CME, which recently paid a dividend on 2025-09-09 with an ex-dividend date of 2025-09-09. Stock splits for the company last occurred on 2012-07-23 when the company split stock in a 5:1 ratio.
Earnings Estimates
. The current assessment of CME Group Inc (CME) involves the perspectives of 14.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $2.68, with high estimates of $2.89 and low estimates of $2.57.
Analysts are recommending an EPS of between $11.51 and $10.86 for the fiscal current year, implying an average EPS of $11.11. EPS for the following year is $11.58, with 18.0 analysts recommending between $12.14 and $10.96.
Revenue Estimates
A total of 9 analysts believe the company’s revenue will be $1.55B this quarter.It ranges from a high estimate of $1.61B to a low estimate of $1.53B. As of. The current estimate, CME Group Inc’s year-ago sales were $1.58BFor the next quarter, 9 analysts are estimating revenue of $1.59B. There is a high estimate of $1.65B for the next quarter, whereas the lowest estimate is $1.55B.
A total of 16 analysts have provided revenue estimates for CME’s current fiscal year. The highest revenue estimate was $6.63B, while the lowest revenue estimate was $6.42B, resulting in an average revenue estimate of $6.5B. In the same quarter a year ago, actual revenue was $6.13BBased on 16 analysts’ estimates, the company’s revenue will be $6.79B in the next fiscal year. The high estimate is $7.23B and the low estimate is $6.49B.
